beta-alanine has been researched along with Elevated Cholesterol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, HP | 1 |
| Yang, X | 1 |
| Lu, K | 1 |
| Wang, SP | 1 |
| Castro-Perez, JM | 1 |
| Previs, S | 1 |
| Wright, M | 1 |
| Shah, V | 1 |
| Herath, K | 1 |
| Xie, D | 1 |
| Szeto, D | 1 |
| Forrest, G | 1 |
| Xiao, JC | 1 |
| Palyha, O | 1 |
| Sun, LP | 1 |
| Andryuk, PJ | 1 |
| Engel, SS | 1 |
| Xiong, Y | 1 |
| Lin, S | 1 |
| Kelley, DE | 1 |
| Erion, MD | 1 |
| Davis, HR | 1 |
| Wang, L | 1 |
| Ogawa, T | 1 |
| Sugidachi, A | 1 |
| Naganuma, H | 1 |
| Asai, F | 1 |
2 other studies available for beta-alanine and Elevated Cholesterol
| Article | Year |
|---|---|
Glucagon receptor antagonism induces increased cholesterol absorption.
Topics: Animals; beta-Alanine; Cholesterol; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Humans; | 2015 |
Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.
Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspiri | 2000 |